Discovery of Bacteroides uniformis F18-22 as a Safe and Novel Probiotic Bacterium for the Treatment of Ulcerative Colitis from the Healthy Human Colon
International Journal of Molecular Sciences · 28.09.2023 · 24 (19) · 14669
DOI: 10.3390/ijms241914669 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 28.09.2023. Verfasst von Wei Dai und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Biological Fermentation Engineering of Beer, Qingdao 266199, China. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Probiotics, Colitis. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Taishan Scholars Program, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Previous studies have demonstrated that the intestinal abundance of Bacteroides uniformis is significantly higher in healthy controls than that in patients with ulcerative colitis (UC). However, what effect B. uniformis has on the development of UC has not been characterized. Here, we show for the first time that B. uniformis F18-22, an alginate-fermenting bacterium isolated from the healthy human colon, protects against dextran-sulfate-sodium (DSS)-induced UC in mice. Specifically, oral intake of B. uniformis F18-22 alleviated colon contraction, improved intestinal bleeding and attenuated mucosal damage in diseased mice. Additionally, B. uniformis F18-22 improved gut dysbiosis in UC mice by increasing the abundance of anti-inflammatory acetate-producing bacterium Eubacterium siraeum and decreasing the amount of pro-inflammatory pathogenetic bacteria Escherichia-Shigella spp. Moreover, B. uniformis F18-22 was well-tolerated in mice and showed no oral toxicity after repeated daily administration for 28 consecutive days. Taken together, our study illustrates that B. uniformis F18-22 is a safe and novel probiotic bacterium for the treatment of UC from the healthy human colon.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Biological Fermentation Engineering of Beer, Qingdao 266199, China.
- Key Laboratory of Marine Drugs of Ministry of Education, Shandong Provincial Key Laboratory of Glycoscience and Glycotechnology, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China.
- Qingdao Marine Biomedical Research Institute, Qingdao 266071, China.
- Laboratory for Marine Drugs and Bioproducts, Qingdao National Laboratory for Marine Science and Technology, Qingdao 266003, China.
ORCID-Profile: Guangli Yu
Förderung
- National Natural Science Foundation of China
- Taishan Scholars Program
- Fundamental Research Funds for the Central Universities
- Natural Science Foundation of Shandong Province
- Research Project of Qingdao Marine Biomed-ical Research Institute
- Shandong Provincial Major Science and Technology Project
- Major Project of Qingdao National Laboratory for Marine Science and Technology
- Taishan Scholar Climbing Project
Zitieren
APA
Dai, W., Zhang, J., Chen, L., Yu, J., Zhang, J., Yin, H., Shang, Q., & Yu, G. (2023). Discovery of Bacteroides uniformis F18-22 as a Safe and Novel Probiotic Bacterium for the Treatment of Ulcerative Colitis from the Healthy Human Colon. International Journal of Molecular Sciences, 24(19), 14669. https://doi.org/10.3390/ijms241914669
Vancouver
Dai W, Zhang J, Chen L, Yu J, Zhang J, Yin H, et al. Discovery of Bacteroides uniformis F18-22 as a Safe and Novel Probiotic Bacterium for the Treatment of Ulcerative Colitis from the Healthy Human Colon. International Journal of Molecular Sciences. 2023;24(19):14669. doi:10.3390/ijms241914669
BibTeX
@article{Dai2023,
author = {Dai, Wei and Zhang, Jiaxue and Chen, Lu and Yu, Junhong and Zhang, Junyi and Yin, Hua and Shang, Qingsen and Yu, Guangli},
title = {Discovery of Bacteroides uniformis F18-22 as a Safe and Novel Probiotic Bacterium for the Treatment of Ulcerative Colitis from the Healthy Human Colon},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {19},
pages = {14669},
doi = {10.3390/ijms241914669}
}
EUVIMED